Intravital Microscopy in Human Solid Tumors
Public ClinicalTrials.gov record NCT03823144. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Intravital Microscopy (IVM) in Human Solid Tumors
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will investigate the tumor-associated vasculature of patients with solid tumors. The investigators will use a technology known as intravital microscopy (IVM) in order to visualize in real-time the vessels associated with solid tumors. The IVM observations may determine if an individual patient's tumor vessels would be amenable to receiving systemic therapy, based on the functionality of the vessels.
Study identification
- NCT ID
- NCT03823144
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 85 participants
Conditions and interventions
Conditions
- Solid Tumor, Adult
- Clinical Stage IV Gastric Cancer AJCC v8
- Malignant Solid Neoplasm
- Metastatic Colorectal Carcinoma
- Metastatic Gastric Carcinoma
- Metastatic Primary Malignant Brain Neoplasm
- Metastatic Sarcoma
- Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8
- Resectable Colorectal Carcinoma
- Resectable Liver and Intrahepatic Bile Duct Carcinoma
- Resectable Pancreatic Carcinoma
- Resectable Sarcoma
- Stage IV Colorectal Cancer AJCC v8
- Anatomic Stage IV Breast Cancer AJCC v8
- Malignant Brain Neoplasm
- Metastatic Breast Carcinoma
- Metastatic Liver Carcinoma
- Metastatic Pancreatic Carcinoma
- Resectable Brain Neoplasm
- Resectable Breast Carcinoma
- Resectable Gastric Carcinoma
- Stage IV Hepatocellular Carcinoma AJCC v8
- Stage IV Pancreatic Cancer AJCC v8
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 27, 2019
- Primary completion
- Sep 29, 2027
- Completion
- Sep 29, 2027
- Last update posted
- Jun 1, 2026
2019 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Florida | Jacksonville | Florida | 32224 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03823144, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 1, 2026 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03823144 live on ClinicalTrials.gov.